Enhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats

International Journal of Cardiology

Volumn 162, Issue 1, 2012, Pages 45-58

  Sun, Cheuk Kwan ^a,b   Lin, Yu Chun ^b   Yuen, Chun Man ^b   Chua, Sarah ^b   Chang, Li Teh ^c   Sheu, Jiunn Jye ^b   Lee, Fan Yen ^b   Fu, Morgan ^b   Leu, Steve ^b   Yip, Hon Kan ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

Author keywords

Bone marrow cells; Monocrotaline; Phosphodiesterase inhibitor

Indexed keywords

CASPASE 3; CONNEXIN 43; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MONOCROTALINE; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C EPSILON; SILDENAFIL; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOLOGOUS BONE MARROW DERIVED ENDOTHELIAL PROGENITOR CELL TRANSPLANTATION; BODY WEIGHT; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; GENE EXPRESSION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE PRESSURE; HEART RIGHT VENTRICLE SYSTOLIC PRESSURE; HEART WEIGHT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG; LUNG ALVEOLUS; LUNG BLOOD VESSEL; LUNG PARENCHYMA; MALE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANIMALS; COMBINED MODALITY THERAPY; ENDOTHELIAL CELLS; HYPERTENSION, PULMONARY; MALE; PIPERAZINES; PURINES; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; SULFONES; VASODILATOR AGENTS;

EID: 84870242807     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.05.002     Document Type: Article

References (45)

1. G.G. Pietra, W.D. Edwards, and J.M. Kay Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry Circulation 80 1989 1198 1206
2. S.P. Gaine, and L.J. Rubin Primary pulmonary hypertension Lancet 352 1998 719 725
3. J.R. Runo, and J.E. Loyd Primary pulmonary hypertension Lancet 361 2003 1533 1544
4. S. Archer, and S. Rich Primary pulmonary hypertension: a vascular biology and translational research "Work in progress" Circulation 102 2000 2781 2791
5. T. Asahara, and A. Kawamoto Endothelial progenitor cells for postnatal vasculogenesis Am J Physiol Cell Physiol 287 2004 C572 C579
6. S. Rich Executive summary from the World Symposium on Primary Pulmonary Hypertension 1998, cosponsored by the World Health Organization Available at: http://wwwwhoint/ncd/cvd/pphhtml1998
7. S. Davani, A. Marandin, and N. Mersin Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model Circulation 108 Suppl. 1 2003 II253 II258
8. B.E. Strauer, M. Brehm, and T. Zeus Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
9. W.Y. Li, Y.J. Choi, and P.H. Lee Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing Cell Transplant 17 2008 1045 1059
10. N. Nagaya, K. Kangawa, and M. Kanda Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells Circulation 108 2003 889 895
11. H.K. Yip, L.T. Chang, and C.K. Sun Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats Crit Care Med 36 2008 873 880
12. Y.D. Zhao, D.W. Courtman, Y. Deng, L. Kugathasan, Q. Zhang, and D.J. Stewart Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease Circ Res 96 2005 442 450
13. X.X. Wang, F.R. Zhang, and Y.P. Shang Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial J Am Coll Cardiol 49 2007 1566 1571
14. M. Sahara, M. Sata, T. Morita, K. Nakamura, Y. Hirata, and R. Nagai Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation Circulation 115 2007 509 517
15. M. Boolell, M.J. Allen, and S.A. Ballard Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction Int J Impot Res 8 1996 47 52
16. M.M. Goldenberg Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction Clin Ther 20 1998 1033 1048
17. H.S. Ahn, M. Foster, M. Cable, B.J. Pitts, and E.J. Sybertz Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues Adv Exp Med Biol 308 1991 191 197
18. K.F. Rabe, H. Tenor, G. Dent, C. Schudt, M. Nakashima, and H. Magnussen Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors Am J Physiol 266 1994 L536 L543
19. L.S. Shekerdemian, H.B. Ravn, and D.J. Penny Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension Am J Respir Crit Care Med 165 2002 1098 1102
20. L. Zhao, N.A. Mason, and N.W. Morrell Sildenafil inhibits hypoxia-induced pulmonary hypertension Circulation 104 2001 424 428
21. T. Itoh, N. Nagaya, and T. Fujii A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats Am J Respir Crit Care Med 169 2004 34 38
22. R.T. Schermuly, K.P. Kreisselmeier, and H.A. Ghofrani Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats Am J Respir Crit Care Med 169 2004 39 45
23. P. Foucher, P. Heeringa, and A.H. Petersen Antimyeloperoxidase-associated lung disease. An experimental model Am J Respir Crit Care Med 160 1999 987 994
24. H.K. Yip, L.T. Chang, and C.J. Wu Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction Circ J 72 2008 1336 1345
25. D.C. Ding, W.C. Shyu, S.Z. Lin, and H. Li The role of endothelial progenitor cells in ischemic cerebral and heart diseases Cell Transplant 16 2007 273 284
26. G.P. Diller, S. van Eijl, and D.O. Okonko Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension Circulation 117 2008 3020 3030
27. A. Luttun, G. Carmeliet, and P. Carmeliet Vascular progenitors: from biology to treatment Trends Cardiovasc Med 12 2002 88 96
28. C.K. Sun, L.T. Chang, and J.J. Sheu Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy Crit Care Med 37 2009 1197 1205
29. T. Thum, J. Bauersachs, P.A. Poole-Wilson, H.D. Volk, and S.D. Anker The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle J Am Coll Cardiol 46 2005 1799 1802
30. Y.M. Chen, W.C. Chiang, S.L. Lin, K.D. Wu, T.J. Tsai, and B.S. Hsieh Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition J Pharmacol Exp Ther 309 2004 978 986
31. Y.M. Chen, C.J. Tu, K.Y. Hung, K.D. Wu, T.J. Tsai, and B.S. Hsieh Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation Br J Pharmacol 138 2003 950 958
32. K.A. Hanson, F. Burns, S.D. Rybalkin, J.W. Miller, J. Beavo, and W.R. Clarke Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message Am J Respir Crit Care Med 158 1998 279 288
33. J. Jalife, G.E. Morley, and D. Vaidya Connexins and impulse propagation in the mouse heart J Cardiovasc Electrophysiol 10 1999 1649 1663
34. S. Kirchhoff, E. Nelles, A. Hagendorff, O. Kruger, O. Traub, and K. Willecke Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice Curr Biol 8 1998 299 302
35. D.L. Lerner, K.A. Yamada, R.B. Schuessler, and J.E. Saffitz Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice Circulation 101 2000 547 552
36. H.I. Yeh, Y.J. Lai, and S.H. Lee Heterogeneity of myocardial sleeve morphology and gap junctions in canine superior vena cava Circulation 104 2001 3152 3157
37. M. Uzzaman, H. Honjo, and Y. Takagishi Remodeling of gap junctional coupling in hypertrophied right ventricles of rats with monocrotaline-induced pulmonary hypertension Circ Res 86 2000 871 878
38. J.P. Blackburn, N.S. Peters, H.I. Yeh, S. Rothery, C.R. Green, and N.J. Severs Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis Arterioscler Thromb Vasc Biol 15 1995 1219 1228
39. H.I. Yeh, F. Lupu, E. Dupont, and N.J. Severs Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery Arterioscler Thromb Vasc Biol 17 1997 3174 3184
40. C.J. Albert, and D.A. Ford Protein kinase C translocation and PKC-dependent protein phosphorylation during myocardial ischemia Am J Physiol 276 1999 H642 H650
41. C.P. Baines, J.M. Pass, and P. Ping Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning Basic Res Cardiol 96 2001 207 218
42. P. Ping, J. Zhang, and Y. Qiu Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity Circ Res 81 1997 404 414
43. P. Ping, H. Takano, and J. Zhang Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning Circ Res 84 1999 587 604
44. T.M. Vondriska, J.B. Klein, and P. Ping Use of functional proteomics to investigate PKC epsilon-mediated cardioprotection: the signaling module hypothesis Am J Physiol Heart Circ Physiol 280 2001 H1434 H1441
45. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2